天沃科技(002564.SZ)擬為張化機引資5億元 引進投資者交銀投資
格隆匯8月23日丨天沃科技(002564.SZ)公佈,公司所屬全資子公司張化機(蘇州)重裝有限公司(以下簡稱“張化機”)擬引進投資者交銀金融資產投資有限公司(以下簡稱“交銀投資”、“投資者”)現金增資人民幣5億元,增資資金擬用於償還公司的金融機構借款。
公司不參與本次增資。公司授權公司總經理林鋼以標的公司評估值為基礎且確保公司對張化機絕對控股的前提下,根據公司與交銀投資最終的商議結果,對交銀投資向上述張化機的增資金額及增資後持股比例予以適當調整。
本次增資完成後,公司將繼續作為張化機控股股東,仍然擁有對張化機的實際控制權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.